PD-1+CXCR5−CD4+ Th-CXCL13 cell subset drives B cells into tertiary lymphoid structures of nasopharyngeal carcinoma

Background A major current challenge is to exploit tertiary lymphoid structures (TLSs) to promote the lymphocyte infiltration, activation and differentiation by tumor antigens to increase antitumor immune responses. The mechanisms that underlie the role of TLS formation in the adaptive immune respon...

Full description

Bibliographic Details
Main Authors: Shu-Mei Yan, Jiang-Ping Li, Chang-You Wu, Ming-Yuan Chen, Shang-Xin Liu, Yin-Feng Kang, Cong Sun, Jennifer R Grandis, Mu-Sheng Zeng, Qian Zhong
Format: Article
Language:English
Published: BMJ Publishing Group 2021-07-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/9/7/e002101.full
id doaj-9ea31ac4952542f9bea1a27c525694b2
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Shu-Mei Yan
Jiang-Ping Li
Chang-You Wu
Ming-Yuan Chen
Shang-Xin Liu
Yin-Feng Kang
Cong Sun
Jennifer R Grandis
Mu-Sheng Zeng
Qian Zhong
spellingShingle Shu-Mei Yan
Jiang-Ping Li
Chang-You Wu
Ming-Yuan Chen
Shang-Xin Liu
Yin-Feng Kang
Cong Sun
Jennifer R Grandis
Mu-Sheng Zeng
Qian Zhong
PD-1+CXCR5−CD4+ Th-CXCL13 cell subset drives B cells into tertiary lymphoid structures of nasopharyngeal carcinoma
Journal for ImmunoTherapy of Cancer
author_facet Shu-Mei Yan
Jiang-Ping Li
Chang-You Wu
Ming-Yuan Chen
Shang-Xin Liu
Yin-Feng Kang
Cong Sun
Jennifer R Grandis
Mu-Sheng Zeng
Qian Zhong
author_sort Shu-Mei Yan
title PD-1+CXCR5−CD4+ Th-CXCL13 cell subset drives B cells into tertiary lymphoid structures of nasopharyngeal carcinoma
title_short PD-1+CXCR5−CD4+ Th-CXCL13 cell subset drives B cells into tertiary lymphoid structures of nasopharyngeal carcinoma
title_full PD-1+CXCR5−CD4+ Th-CXCL13 cell subset drives B cells into tertiary lymphoid structures of nasopharyngeal carcinoma
title_fullStr PD-1+CXCR5−CD4+ Th-CXCL13 cell subset drives B cells into tertiary lymphoid structures of nasopharyngeal carcinoma
title_full_unstemmed PD-1+CXCR5−CD4+ Th-CXCL13 cell subset drives B cells into tertiary lymphoid structures of nasopharyngeal carcinoma
title_sort pd-1+cxcr5−cd4+ th-cxcl13 cell subset drives b cells into tertiary lymphoid structures of nasopharyngeal carcinoma
publisher BMJ Publishing Group
series Journal for ImmunoTherapy of Cancer
issn 2051-1426
publishDate 2021-07-01
description Background A major current challenge is to exploit tertiary lymphoid structures (TLSs) to promote the lymphocyte infiltration, activation and differentiation by tumor antigens to increase antitumor immune responses. The mechanisms that underlie the role of TLS formation in the adaptive immune responses against nasopharyngeal carcinoma (NPC) remain largely unknown.Methods Cell populations and the corresponding markers were identified by single-cell RNA sequencing and fluorescence-activated cell sorting analysis. In vitro differentiation experiments were used to simulate the generation, regulation and function of the Th-CXCL13 cell subset in the tumor microenvironment of NPC. These were followed by histological evaluation of the colocalization of tumor-associated B cells (TABs) and Th-CXCL13 cells within TLSs, and statistical analysis of the relationship between the cells in TLSs and overall survival.Results A PD-1+CXCR5−CD4+ Th-CXCL13 cell subset was identified in NPC. This subset was a major source of CXCL13, representing the majority of the CD4+ T cells at levels comparable with Th1 and Tfh cells present in the TLSs. Monocytes activated by toll-like receptor 4 agonists served as the antigen-presenting cells that most efficiently triggered the expansion of Th-CXCL13 cells. Transforming growth factor beta 1 (TGF-β1) stimulation and activation of Sox4 were critical for the induction and polarization of Th-CXCL13 cells in this process. The potential functional contributions of TABs recruited by Th-CXCL13 cells which induced plasma cell differentiation and immunoglobulin production via interleukin-21 and CD84 interactions in the TLSs demonstrated improved survival.Conclusions Induction of Th-CXCL13 cells links innate inflammation to immune privilege in tumor-associated TLSs and might predict better survival.
url https://jitc.bmj.com/content/9/7/e002101.full
work_keys_str_mv AT shumeiyan pd1cxcr5cd4thcxcl13cellsubsetdrivesbcellsintotertiarylymphoidstructuresofnasopharyngealcarcinoma
AT jiangpingli pd1cxcr5cd4thcxcl13cellsubsetdrivesbcellsintotertiarylymphoidstructuresofnasopharyngealcarcinoma
AT changyouwu pd1cxcr5cd4thcxcl13cellsubsetdrivesbcellsintotertiarylymphoidstructuresofnasopharyngealcarcinoma
AT mingyuanchen pd1cxcr5cd4thcxcl13cellsubsetdrivesbcellsintotertiarylymphoidstructuresofnasopharyngealcarcinoma
AT shangxinliu pd1cxcr5cd4thcxcl13cellsubsetdrivesbcellsintotertiarylymphoidstructuresofnasopharyngealcarcinoma
AT yinfengkang pd1cxcr5cd4thcxcl13cellsubsetdrivesbcellsintotertiarylymphoidstructuresofnasopharyngealcarcinoma
AT congsun pd1cxcr5cd4thcxcl13cellsubsetdrivesbcellsintotertiarylymphoidstructuresofnasopharyngealcarcinoma
AT jenniferrgrandis pd1cxcr5cd4thcxcl13cellsubsetdrivesbcellsintotertiarylymphoidstructuresofnasopharyngealcarcinoma
AT mushengzeng pd1cxcr5cd4thcxcl13cellsubsetdrivesbcellsintotertiarylymphoidstructuresofnasopharyngealcarcinoma
AT qianzhong pd1cxcr5cd4thcxcl13cellsubsetdrivesbcellsintotertiarylymphoidstructuresofnasopharyngealcarcinoma
_version_ 1721222206162206720
spelling doaj-9ea31ac4952542f9bea1a27c525694b22021-08-04T16:30:29ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262021-07-019710.1136/jitc-2020-002101PD-1+CXCR5−CD4+ Th-CXCL13 cell subset drives B cells into tertiary lymphoid structures of nasopharyngeal carcinomaShu-Mei Yan0Jiang-Ping Li1Chang-You Wu2Ming-Yuan Chen3Shang-Xin Liu4Yin-Feng Kang5Cong Sun6Jennifer R Grandis7Mu-Sheng Zeng8Qian Zhong9Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, People's Republic of ChinaSun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, People's Republic of ChinaInstitute of Immunology, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, People's Republic of ChinaSun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, People's Republic of ChinaSun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, People's Republic of ChinaSun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, People's Republic of ChinaSun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, People's Republic of ChinaDepartment of Otolaryngology–Head and Neck Surgery, University of California, San Francisco, California, USASun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, People's Republic of ChinaSun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, People's Republic of ChinaBackground A major current challenge is to exploit tertiary lymphoid structures (TLSs) to promote the lymphocyte infiltration, activation and differentiation by tumor antigens to increase antitumor immune responses. The mechanisms that underlie the role of TLS formation in the adaptive immune responses against nasopharyngeal carcinoma (NPC) remain largely unknown.Methods Cell populations and the corresponding markers were identified by single-cell RNA sequencing and fluorescence-activated cell sorting analysis. In vitro differentiation experiments were used to simulate the generation, regulation and function of the Th-CXCL13 cell subset in the tumor microenvironment of NPC. These were followed by histological evaluation of the colocalization of tumor-associated B cells (TABs) and Th-CXCL13 cells within TLSs, and statistical analysis of the relationship between the cells in TLSs and overall survival.Results A PD-1+CXCR5−CD4+ Th-CXCL13 cell subset was identified in NPC. This subset was a major source of CXCL13, representing the majority of the CD4+ T cells at levels comparable with Th1 and Tfh cells present in the TLSs. Monocytes activated by toll-like receptor 4 agonists served as the antigen-presenting cells that most efficiently triggered the expansion of Th-CXCL13 cells. Transforming growth factor beta 1 (TGF-β1) stimulation and activation of Sox4 were critical for the induction and polarization of Th-CXCL13 cells in this process. The potential functional contributions of TABs recruited by Th-CXCL13 cells which induced plasma cell differentiation and immunoglobulin production via interleukin-21 and CD84 interactions in the TLSs demonstrated improved survival.Conclusions Induction of Th-CXCL13 cells links innate inflammation to immune privilege in tumor-associated TLSs and might predict better survival.https://jitc.bmj.com/content/9/7/e002101.full